JTCS KCI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Byrne, J. G.
Right arrow Articles by Cohn, L. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Byrne, J. G.
Right arrow Articles by Cohn, L. H.

The Journal of Thoracic and Cardiovascular Surgery, Vol 104, 1589-1596, Copyright © 1992 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association


ARTICLES

Complete prevention of myocardial stunning, contracture, low-reflow, and edema after heart transplantation by blocking neutrophil adhesion molecules during reperfusion

JG Byrne, WJ Smith, MP Murphy, GS Couper, RF Appleyard and LH Cohn
Department of Surgery, Harvard Medical School, Boston, Mass.

This study tested the hypothesis that preventing neutrophil adhesion during reperfusion, by blocking either the neutrophil membrane CD18 integrin complex or its endothelial and myocyte ligand, intercellular adhesion molecule-1 (ICAM-1), would reduce myocardial inflammation and edema and improve reflow and ventricular function after heart preservation and transplantation. After cardioplegia and insertion of a left ventricular balloon, rabbit hearts were heterotopically transplanted into recipient rabbits either immediately (immediate, n = 12) or after preservation in 4 degrees C saline (3 hours of ischemia, n = 33). Forty-five minutes before reperfusion, recipients of preserved hearts received intravenous infusions of either saline (vehicle, n = 13), anti-CD18 monoclonal antibody (Mab) R15.7 (2 mg/kg) (anti-CD18, n = 10), or anti-ICAM-1 Mab R1.1 (2 mg/kg) (anti-ICAM, n = 10). During 3 hours of reperfusion the slope of the peak-systolic pressure-volume relation and its volume-axis intercept, the exponential elastic coefficient of the end-diastolic pressure-volume relation, the unstressed ventricular volume, and the time constant of the exponential left ventricular pressure decay after dP/dtmin were serially measured. Myocardial blood flow was measured with microspheres from which coronary vascular resistance was calculated. After explanation, the degree of myocardial inflammation, estimated by tissue neutrophil sequestration (myeloperoxidase assay) and myocardial water content were determined. Within each group no significant differences in measurements made at 1, 2, and 3 hours of reperfusion were noted. Compared with the immediate transplantation group, the vehicle group demonstrated a significant increase in myeloperoxidase activity (3380 +/- 456 versus 1712 +/- 552 microU/gm, p < 0.05), coronary vascular resistance (115.5 +/- 13.4 versus 70.5 +/- 10.6 U/gm, p < 0.05), and myocardial water content (79.8% +/- 0.4% versus 75.6% +/- 1.3%, p < 0.05), a significant decrease in unstressed ventricular volume (a leftward shift in the end-diastolic pressure-volume relation) (-0.49 +/- 0.24 versus 0.28 +/- 0.21 ml, p < 0.05), and a marked prolongation in exponential left ventricular pressure delay after dP/dtmin (156.64 +/- 3.81 versus 37.25 +/- 3.34 msec, p < 0.01).(ABSTRACT TRUNCATED AT 400 WORDS)


This article has been cited by other articles:


Home page
Cardiovasc ResHome page
S. F. Rodrigues and D. N. Granger
Role of blood cells in ischaemia-reperfusion induced endothelial barrier failure
Cardiovasc Res, July 15, 2010; 87(2): 291 - 299.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. A. Gorog, R. A. Foale, and I. Malik
Distal Myocardial Protection During Percutaneous Coronary Intervention: When and Where?
J. Am. Coll. Cardiol., October 18, 2005; 46(8): 1434 - 1445.
[Abstract] [Full Text] [PDF]


Home page
Asian Cardiovasc. Thorac. Ann.Home page
M. P Vallely, P. G Bannon, C. F Hughes, and L. Kritharides
Endothelial Cell Adhesion Molecules and Cardiopulmonary Bypass
Asian Cardiovasc Thorac Ann, December 1, 2001; 9(4): 349 - 355.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
M. Redlin, J. Werner, H. Habazettl, W. Griethe, H. Kuppe, and A. R. Pries
Cariporide (HOE 642) Attenuates Leukocyte Activation in Ischemia and Reperfusion
Anesth. Analg., December 1, 2001; 93(6): 1472 - 1479.
[Abstract] [Full Text] [PDF]


Home page
PerfusionHome page
A Sablotzki, J Muhling, M G Dehne, B Zickmann, R E Silber, and I Friedrich
Treatment of sepsis in cardiac surgery: role of immunoglobulins
Perfusion, March 1, 2001; 16(2): 113 - 120.
[Abstract] [PDF]


Home page
Cardiovasc ResHome page
J. M Budde, D. A Velez, Z.-Q. Zhao, K. L Clark, C. D Morris, S. Muraki, R. A Guyton, and J. Vinten-Johansen
Comparative study of AMP579 and adenosine in inhibition of neutrophil-mediated vascular and myocardial injury during 24 h of reperfusion
Cardiovasc Res, August 1, 2000; 47(2): 294 - 305.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
R. Kalawski, E. Deskur, P. Bugajski, H. Wysocki, and T. Siminiak
STIMULATION OF NEUTROPHIL INTEGRIN EXPRESSION DURING CORONARY ARTERY BYPASS GRAFTING: COMPARISON OF CRYSTALLOID AND BLOOD CARDIOPLEGIC SOLUTIONS
J. Thorac. Cardiovasc. Surg., June 1, 2000; 119(6): 1270 - 1277.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
A. Alonso, C. W. Whitten, and G. E. Hill
Pump prime only aprotinin inhibits cardiopulmonary bypass-induced neutrophil CD11b up-regulation
Ann. Thorac. Surg., February 1, 1999; 67(2): 392 - 395.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. Boldt, B. Kumle, M. Papsdorf, and G. Hempelmann
Are Circulating Adhesion Molecules Specifically Changed in Cardiac Surgical Patients?
Ann. Thorac. Surg., March 1, 1998; 65(3): 608 - 614.
[Abstract] [Full Text] [PDF]


Home page
Eur J Cardiothorac SurgHome page
G. Zund, A. L. Dzus, R. Pretre, U. Niederhauser, P. Vogt, and M. Turina
Endothelial cell injury in cardiac surgery: salicylate may be protective by reducing expression of endothelial adhesion molecules
Eur J Cardiothorac Surg, March 1, 1998; 13(3): 293 - 297.
[Abstract] [Full Text] [PDF]


Home page
PerfusionHome page
H E Hogevold, O Moen, E Fosse, P Venge, J Braten, C Andersson, and T Lyberg
Effects of heparin coating on the expression of CD11b, CD11c and CD62L by leucocytes in extracorporeal circulation in vitro
Perfusion, January 1, 1997; 12(1): 9 - 20.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
E. M. Boyle Jr, T. H. Pohlman, C. J. Cornejo, and E. D. Verrier
Endothelial Cell Injury in Cardiovascular Surgery: Ischemia-Reperfusion
Ann. Thorac. Surg., December 1, 1996; 62(6): 1868 - 1875.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
T. Miura, D. P. Nelson, M. L. Schermerhorn, T. Shin'oka, G. Zund, P. R. Hickey, E. J. Neufeld, and J. E. Mayer Jr
Blockade of Selectin-Mediated Leukocyte Adhesion Improves Postischemic Function in Lamb Hearts
Ann. Thorac. Surg., November 1, 1996; 62(5): 1295 - 1300.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
E. D. Verrier and E. M. Boyle Jr
Endothelial Cell Injury in Cardiovascular Surgery
Ann. Thorac. Surg., September 1, 1996; 62(3): 915 - 922.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
S. A. Buchanan, M. C. Mauney, N. F. deLima, O. A. R. Binns, J. S. Cope, K. S. Shockey, S. G. Gordon, M. B. Erwin, G. Sutherland, I. L. Kron, et al.
ENHANCED ISOLATED LUNG FUNCTION AFTER ISCHEMIA WITH ANTININTERCELLULAR ADHESION MOLECULE ANTIBODY
J. Thorac. Cardiovasc. Surg., May 1, 1996; 111(5): 941 - 947.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
R. A. Schmid, M. Yamashita, K. Ando, Y. Tanaka, J. D. Cooper, and G. A. Patterson
Lidocaine Reduces Reperfusion Injury and Neutrophil Migration in Canine Lung Allografts
Ann. Thorac. Surg., March 1, 1996; 61(3): 949 - 955.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
R. Pabla, A. J. Buda, D. M. Flynn, S. A. Blesse, A. M. Shin, M. J. Curtis, and D. J. Lefer
Nitric Oxide Attenuates Neutrophil-Mediated Myocardial Contractile Dysfunction After Ischemia and Reperfusion
Circ. Res., January 1, 1996; 78(1): 65 - 72.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
G. E. Hill, A. Alonso, J. R. Spurzem, A. H. Stammers, and R. A. Robbins
APROTININ AND METHYLPREDNISOLONE EQUALLY BLUNT CARDIOPULMONARY BYPASS-INDUCED INFLAMMATION IN HUMANS
J. Thorac. Cardiovasc. Surg., December 1, 1995; 110(6): 1658 - 1662.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
J. M. Forbess, T. Hiramatsu, F. Nomura, T. Miura, G. K. Farrington, K. Sokolowski, M. Bree, and J. E. Mayer Jr
Anti-CD11b monoclonal antibody improves myocardial function after six hours of hypothermic storage
Ann. Thorac. Surg., November 1, 1995; 60(5): 1238 - 1244.
[Abstract] [PDF]


Home page
CirculationHome page
J. P. Slater, M. M.R. Amirhamzeh, O. J. Yano, A. S. Shah, J. P. Starr, R. J. Kaplon, W. Burfeind, P. Pepino, R. E. Michler, E. A. Rose, et al.
Discriminating Between Preservation and Reperfusion Injury in Human Cardiac Allografts Using Heart Weight and Left Ventricular Mass
Circulation, November 1, 1995; 92(9): 223 - 227.
[Abstract] [Full Text]


Home page
CirculationHome page
P. Menasche, J. Peynet, N. Haeffner-Cavaillon, M.-P. Carreno, T. de Chaumaray, V. Dillisse, B. Faris, A. Piwnica, G. Bloch, and A. Tedgui
Influence of Temperature on Neutrophil Trafficking During Clinical Cardiopulmonary Bypass
Circulation, November 1, 1995; 92(9): 334 - 340.
[Abstract] [Full Text]


Home page
CirculationHome page
F. Le Deist, P. Menasche, C. Kucharski, A. Bel, A. Piwnica, and G. Bloch
Hypothermia During Cardiopulmonary Bypass Delays but Does Not Prevent Neutrophil Endothelial Cell Adhesion : A Clinical Study
Circulation, November 1, 1995; 92(9): 354 - 358.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
F. C. Faes, Y. Sawa, H. Ichikawa, Y. Shimazaki, T. Ohashi, H. Fukuda, R. Shirakura, and H. Matsuda
Inhibition of Na+/H+ exchanger attenuates neutrophil-mediated reperfusion injury
Ann. Thorac. Surg., August 1, 1995; 60(2): 377 - 381.
[Abstract] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
B. Frering, I. Philip, M. Dehoux, C. Rolland, J. M. Langlois, and J. M. Desmonts
Circulating cytokines in patients undergoing normothermic cardiopulmonary bypass
J. Thorac. Cardiovasc. Surg., October 1, 1994; 108(4): 636 - 641.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
P. M. Kilbridge, J. E. Mayer, J. W. Newburger, P. R. Hickey, A. Z. Walsh, and E. J. Neufeld
Induction of intercellular adhesion molecule-1 and E-selectin mRNA in heart and skeletal muscle of pediatric patients undergoing cardiopulmonary bypass
J. Thorac. Cardiovasc. Surg., May 1, 1994; 107(5): 1183 - 1192.
[Abstract] [Full Text]


Home page
PerfusionHome page
D. A Palanzo, N. J Manley, R. M Montesano, G. L Yeisley, and D. Gordon
Clinical evaluation of the LeukoGuard (LG-6) arterial line filter for routine open-heart surgery
Perfusion, November 1, 1993; 8(6): 489 - 496.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1992 by The American Association for Thoracic Surgery.